Plasma Lipid Profile Reveals Plasmalogens as Potential Biomarkers for Colon Cancer Screening

In this era of precision medicine, there is an increasingly urgent need for highly sensitive tests for detecting tumors such as colon cancer (CC), a silent disease where the first symptoms may take 10–15 years to appear. Mass spectrometry-based lipidomics is an emerging tool for such clinical diagno...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Metabolites
Autors principals: Fernandes, Anna Maria A.P., Messias, Marcia C.F., Duarte, Gustavo H.B., de Santis, Gabrielle K.D., Mecatti, Giovana C., Porcari, Andreia M., Murgu, Michael, Simionato, Ana Valéria C., Rocha, Thalita, Martinez, Carlos A.R., Carvalho, Patricia O.
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7345851/
https://ncbi.nlm.nih.gov/pubmed/32630389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo10060262
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars